Virbac will raise prices on sentinel as soon as they can. No way to afford the hiring without raising prices. The have no plans to support the sentinel line. They will be lucky to sell $50 million next year. Expect big layoffs by Q3.
Parasiticide vaccine for the protection against canine leishmaniosis based on leishmania infantum excreted-secreted proteins.
What else? This one not a real mover in the U.S.
